Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Carcinogenesis|September 9, 2010
The FOXM1 transcriptional factor promotes the proliferation of leukemia cells through modulation of cell cycle progression in acute myeloid leukemiaSatoki Nakamura, Isao Hirano, Keiji Okinaka, et al.
Internal Medicine (Tokyo, Japan)|February 5, 2019
Cardiotoxicity of Carfilzomib in Two Japanese Patients with Relapsed Multiple MyelomaTakenori Ikoma, Masao Saotome, Makoto Sano, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|October 12, 2018
[A case of obstructive pancreatitis induced by extramedullary pancreatic metastasis in a patient with immunoglobulin D multiple myeloma]Masahiro Umemura, Takeshi Chida, Erika Matsunaga, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 3, 2014
Acquired factor X deficiency developed four years after autologous transplantation in a patient with multiple myeloma associated with systemic AL amyloidosisTomonari Takemura, Yusuke Fukatsu, Yasuyuki Nagata, et al.
International Journal of Hematology|October 28, 2017
Nilotinib vs. imatinib in Japanese patients with newly diagnosed chronic myeloid leukemia in chronic phase: long-term follow-up of the Japanese subgroup of the randomized ENESTnd trialHirohisa Nakamae, Tetsuya Fukuda, Chiaki Nakaseko, et al.
Leukemia Research Reports|May 5, 2022
Successful treatment with nilotinib after bosutinib-induced pulmonary arterial hypertension recurrence following dasatinib in chronic myeloid leukemia in chronic phaseIbuki Takatsuka, Hiroya Hirata, Takumi Takahashi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 10, 2019
[Sarcoidosis-lymphoma syndrome showing abnormal FDG uptake in lymph nodes and muscles upon post-chemotherapy PET/CT imaging]Kotaro Nakano, Yujiro Ito, Fumisato Takagi, et al.
International Journal of Hematology|September 11, 2021
Nilotinib vs. imatinib in Japanese patients with newly diagnosed chronic myeloid leukemia in chronic phase: 10-year follow‑up of the Japanese subgroup of the randomized ENESTnd trialHirohisa Nakamae, Masahide Yamamoto, Emiko Sakaida, et al.
International Journal of Hematology|August 13, 2022
Bosutinib in Japanese patients with newly diagnosed chronic-phase chronic myeloid leukemia: final 3-year follow-up results of a phase 2 studyTakaaki Ono, Masayuki Hino, Itaru Matsumura, et al.
International Journal of Hematology|September 12, 2025
Long-term immunity to measles and rubella after vaccination in adult allogeneic hematopoietic stem cell transplant recipientsSatoshi Dohtan, Yasuyuki Nagata, Mitsuru Yamashita, et al.
Pageof 7